Long‐term safety and efficacy of ritlecitinib in adults and adolescents with alopecia areata and at least 25% scalp hair loss: Results from the ALLEGRO‐LT phase 3, open‐label study

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	C. Tziotzios, R. Sinclair, A. Lesiak, S. Mehlis, M. Kinoshita‐Ise, A. Tsianakas, X. Luo, E. H. Law, R. Ishowo‐Adejumo, R. Wolk, M. Sadrarhami, A. Lejeune
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	Journal of the European Academy of Dermatology and Venereology
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

Similar Items